{"Symbol": "LJPC", "AssetType": "Common Stock", "Name": "La Jolla Pharmaceutical Company", "Description": "La Jolla Pharmaceutical Company, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for life-threatening diseases. The company offers GIAPREZA (angiotensin II), a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock. It is also developing LJPC-0118 for the treatment of severe malaria; and LJPC-401 (synthetic human hepcidin), an investigational product to treat conditions characterized by iron overload. The company was founded in 1989 and is headquartered in San Diego, California.", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "Healthcare", "Industry": "Biotechnology", "Address": "4550 Towne Centre Court, San Diego, CA, United States, 92121", "FullTimeEmployees": "90", "FiscalYearEnd": "December", "LatestQuarter": "2020-06-30", "MarketCapitalization": "111910992", "EBITDA": "-140292992", "PERatio": "None", "PEGRatio": "-0.53", "BookValue": "-0.608", "DividendPerShare": "None", "DividendYield": "0", "EPS": "-5.922", "RevenuePerShareTTM": "0.968", "ProfitMargin": "-2.9823", "OperatingMarginTTM": "-2.7413", "ReturnOnAssetsTTM": "-0.3256", "ReturnOnEquityTTM": "-6.865", "RevenueTTM": "26352000", "GrossProfitTTM": "20662000", "DilutedEPSTTM": "-2.887", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "0.018", "AnalystTargetPrice": "10.67", "TrailingPE": "0", "ForwardPE": "0", "PriceToSalesRatioTTM": "4.1107", "PriceToBookRatio": "0", "EVToRevenue": "2.6291", "EVToEBITDA": "0", "Beta": "2.4319", "52WeekHigh": "11.41", "52WeekLow": "2.3", "50DayMovingAverage": "4.075", "200DayMovingAverage": "5.4639", "SharesOutstanding": "27298800", "SharesFloat": "10100446", "SharesShort": "3180877", "SharesShortPriorMonth": "3500767", "ShortRatio": "6.27", "ShortPercentOutstanding": "0.13", "ShortPercentFloat": "0.1884", "PercentInsiders": "5.993", "PercentInstitutions": "83.605", "ForwardAnnualDividendRate": "0", "ForwardAnnualDividendYield": "0", "PayoutRatio": "0", "DividendDate": "None", "ExDividendDate": "None", "LastSplitFactor": "1:50", "LastSplitDate": "2014-01-14"}